arrow
O

Olivier Govaere

newcastle university
H指数:47
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis

整合多组学分析揭示代谢功能障碍相关脂肪性肝炎进展过程中巨噬细胞的特异性改变

2026-05-180
OAAI
STAT1 drives the immune landscape of murine Toll-like receptor 9-induced liver inflammation

STAT1驱动小鼠Toll样受体9诱导的肝脏炎症的免疫景观

2025-11-060
OAAI
Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation

脂肪性肝病诱导YAP/TAZ驱动的细胞竞争,该竞争可抑制肿瘤起始

2025-06-060
PREAI
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality

胰岛素样生长因子-1反映肝脏疾病分期并改善肝相关死亡预测

2025-05-140
OAAI
Pharmacogene expression during progression of metabolic dysfunction-associated steatotic liver disease: Studies on mRNA and protein levels and their relevance to drug treatment

代谢功能障碍相关脂肪变性肝病进展过程中的药理学表达: mRNA和蛋白质水平及其与药物治疗相关性的研究

2024-10-012
OAAI
An unbiased ranking of murine dietary models based on their proximity to human metabolic dysfunction-associated steatotic liver disease (MASLD)

基于与人类代谢功能障碍相关的脂肪变性肝病 (MASLD) 的接近程度,对小鼠饮食模型进行无偏排名

2024-06-1233
OA
Adipose tissue macrophage dysfunction is associated with a breach of vascular integrity in NASH
2024-03-014
OA
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease

PNPLA3 rs738409基因多态性对非酒精性脂肪性肝病患者肝脏相关事件发生的影响

2023-12-0119
OAAI
Serum levels of fibrogenesis biomarkers reveal distinct endotypes predictive of response to weight loss in advanced nonalcoholic fatty liver disease

纤维生成生物标志物的血清水平揭示了晚期非酒精性脂肪性肝病对体重减轻反应的不同内型预测

2023-10-011
OAAI
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling

肠道b细胞许可NASH微生物群中代谢T细胞活化/抗原独立,并通过IgA-FcR信号传导促进纤维化

2023-08-0137
OAAI
Sublethal necroptosis signaling promotes inflammation and liver cancer

亚致死坏死性凋亡信号促进炎症和肝癌

IMMUNITY
IF26.3
2023-07-0144
OA
Genome-wide association study of non- alcoholic fatty liver and steatohepatitis in a histologically characterised cohort( vol 73, pp 505-515 , 2020 )
2023-05-012
OA
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate

鉴定ERAP2表达降低和新的HLA等位基因作为阿莫西林-克拉维酸盐引起肝损伤易感性风险评分的组成部分

2023-03-0122
OA